Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Int J Med Inform ; 152: 104443, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34004398

RESUMEN

INTRODUCTION: Current lengthening of average life and constant increase of population ageing associated to forces that include rapid unplanned urbanisation and globalisation of unhealthy behaviours have determined the huge relevance of noncommunicable diseases (NCDs). Monitoring key modifiable behavioural risk factors has resulted to be crucial both in spatial terms and as per temporal trends in order to allow comparisons between different geographic areas or levels and over time. MATERIALS AND METHODS: In Italy, PASSI (Progressi delle Aziende Sanitarie per la Salute in Italia) and Passi d'Argento are the ongoing Behavioural Risk Factor Surveillance Systems (BRFSSs), respectively, on adults (people aged 18-69) and elderly (65 and older). RESULTS: The two Italian surveillances are information systems providing data not only on the third Sustainable Development Goal (SDG) that explicitly addresses ensuring healthy lives and promoting well-being for all, but on a total of nine health-related SDGs (HRSDGs) and 19 HRSDG targets/indicators. We describe these pairs more in detail specifying where in case of BRFSS core indicators (N = 14 HRSDG targets/indicators) concerning six HRSDGs or, on the other hand, as per BRFSS further in-depth analysis (N = five HRSDG targets/indicators) in regard of four different HRSDGs. About the HRSDG 3, HRSDG target 3.4, HRSDG indicator 3.4.1, from the PASSI and Passi d'Argento data it is possible not only to detect the prevalence of NCDs in adults and elderly living in Italy, but also to evaluate the social determinants of health, such as gender, age group, educational level, economic difficulties, as well as the associations with modifiable lifestyle risk factors. CONCLUSIONS: The two Italian BRFSSs generate accurate data, which are highly relevant to design, implement, monitor, and evaluate programs and policies at different levels (local, regional, national) for NCD prevention and health promotion. They provide numbers which can also serve as propaedeutic or, in some cases, complementary ground to address a robust measurement of several HRSDG patterns.


Asunto(s)
Objetivos , Desarrollo Sostenible , Adulto , Anciano , Humanos , Sistemas de Información , Italia/epidemiología , Factores de Riesgo
2.
Europace ; 11(7): 902-9, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19443431

RESUMEN

AIMS: We tested apnoea/hypopnoea index (AHI), high-sensitivity (hs) C-reactive protein and clinical/instrumental variables as predictors of atrial fibrillation (AF) recurrence over 1-year follow-up after successful electrical cardioversion. METHODS AND RESULTS: We enrolled 158 consecutive patients. Apnoea/hypopnoea index was assessed with standard overnight polysomnography and hs-C-reactive protein with immunonephelometry assay the day before electrical cardioversion. Atrial fibrillation recurrences occurred in 81 patients (51%). Predictors at univariate analysis were: AHI > or = 15 events/h (P = 0.001), hs-C-reactive protein >0.30 mg/dL (P = 0.009), AF duration >3 days (P = 0.008), diabetes (P = 0.03), and ongoing anti-arrhythmic therapy at the time of electrical cardioversion (P = 0.03). Survival analysis confirmed that patients with AHI > or = 15 events/h and hs-C-reactive protein > 0.30 mg/dL had a higher recurrence rate of AF (log rank P = 0.0006 and P = 0.01, respectively). Predictors at multivariate analysis were: AHI > or = 15 events/h (P = 0.003), hs-C-reactive protein > 0.30 mg/dL (P = 0.01) and ongoing anti-arrhythmic therapy (P = 0.04). A predictive model based upon the multiple effects of significant variables plus age as a continuous variable stratified the risk of AF recurrence, more than tripled with all dichotomized variables altered with respect to normal variables (85 vs. 27%). CONCLUSION: AHI > or = 15 events/h and hs-C-reactive protein > 0.30 mg/dL are the strongest predictors of the predictors chosen of AF recurrence after successful electrical cardioversion over 1-year follow-up.


Asunto(s)
Fibrilación Atrial/diagnóstico , Fibrilación Atrial/prevención & control , Proteína C-Reactiva/análisis , Estimulación Cardíaca Artificial/métodos , Evaluación de Resultado en la Atención de Salud/métodos , Modelos de Riesgos Proporcionales , Apnea Obstructiva del Sueño/diagnóstico , Adulto , Anciano , Fibrilación Atrial/sangre , Femenino , Humanos , Masculino , Recurrencia , Reproducibilidad de los Resultados , Medición de Riesgo/métodos , Factores de Riesgo , Sensibilidad y Especificidad , Resultado del Tratamiento
3.
J Cardiovasc Med (Hagerstown) ; 14(7): 520-7, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22441219

RESUMEN

AIMS: P maximum/P dispersion and high-sensitivity C-reactive protein (hs-C-reactive protein) have been proposed as useful markers for predicting the history and recurrence of atrial fibrillation. We tested the association between hs-C-reactive protein and maximum P-wave duration (P maximum)/P-wave dispersion (P dispersion) in hypertensive patients after conversion of atrial fibrillation. METHODS: We enrolled 92 patients. Hs-C-reactive protein was assessed before cardioversion, the 12-lead ECG was recorded immediately after sinus rhythm restoration. RESULTS: At univariate analysis P maximum above 120  ms was associated with male sex (P = 0.0009), body mass index at least 25  kg/m (P = 0.03) and hs-C-reactive protein greater than 0.30  mg/dl (P = 0.0001), and left atrium diameter greater than 40 mm nearly significant (P = 0.05). P dispersion above 40  ms was associated with hs-C-reactive protein greater than 0.30  mg/dl (P = 0.0001) and left atrium diameter greater than 0.40  mm (P = 0.03). P maximum/P dispersion (mean ±â€ŠSD) was significantly longer in patients with hs-C-reactive protein greater than 0.30  mg/dl compared to patients with hs-C-reactive protein 0.30  mg/dl or less (P = 0.0001 for both). At multivariate analysis P maximum above 120  ms was associated with male sex (P = 0.01) and with hs-C-reactive protein greater than 0.30  mg/dl (P = 0.002), whereas P dispersion above 40  ms was associated only with hs-C-reactive protein greater than 0.30  mg/dl (P = 0.0006). CONCLUSION: Male sex and hs-C-reactive protein were associated with P maximum above 120  ms; hs-C-reactive protein was also associated with P dispersion above 40  ms in hypertensive patients after conversion of atrial fibrillation. Subclinical inflammation may be associated with delayed/inhomogeneous atrial activation in hypertensive patients affected by atrial fibrillation.


Asunto(s)
Fibrilación Atrial/fisiopatología , Proteína C-Reactiva/metabolismo , Hipertensión/fisiopatología , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/metabolismo , Biomarcadores/metabolismo , Estudios de Cohortes , Cardioversión Eléctrica , Electrocardiografía , Femenino , Estudios de Seguimiento , Humanos , Hipertensión/metabolismo , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia , Factores Sexuales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA